Do We Have the Real Tools to Evaluate Lung Radiotoxicity

作者: F. Mornex , L. J. Boersma

DOI: 10.1007/978-3-642-59824-1_19

关键词: Pulmonary function testingMedicineLung cancerInternal medicineStandard treatmentAsymptomaticBreast cancerLungOncologyLung injuryRadiation therapy

摘要: Lung cancer remains a devastating disease. In many situations, radiation therapy represents chance of cure. However, due to the high radiosensitivity lung, it is often not possible achieve tumoricidal dose in lung patients. addition, patients who are cured by radiotherapy, quality life may be compromised an impaired respiratory function. Radiation-induced pulmonary symptoms occur up approximately 20% irradiated for breast cancer, lymphoma and thymoma (MARKS 1997b). Subclinical changes whole-lung function, manifested asymptomatic reductions quantitative function tests, seen larger fraction For individual patient, there presently no good means predicting probability developing symptoms, nor severity injury induced therapy, alone or combined with chemotherapy, which becoming standard treatment some situations (PECKHAM COLLIS 1981; SCHAAKE-KONING et al. 1992).

参考文章(94)
Walter J. Curran, Philip J. Moldofsky, Lawrence J. Solin, Observations on the predictive value of perfusion lung scans on post-irradiation pulmonary function among 210 patients with bronchogenic carcinoma International Journal of Radiation Oncology*Biology*Physics. ,vol. 24, pp. 31- 36 ,(1992) , 10.1016/0360-3016(92)91017-H
Stuart W. Cosgriff, Morton M. Kligerman, Use of ACTH and Cortisone in the Treatment of Post-Irradiation Pulmonary Reaction Radiology. ,vol. 57, pp. 536- 540 ,(1951) , 10.1148/57.4.536
L J Boersma, E M Damen, R W de Boer, S H Muller, R A Valdés Olmos, N van Zandwijk, J V Lebesque, Recovery of overall and local lung function loss 18 months after irradiation for malignant lymphoma. Journal of Clinical Oncology. ,vol. 14, pp. 1431- 1441 ,(1996) , 10.1200/JCO.1996.14.5.1431
Caro Schaake-Koning, Walter van den Bogaert, Otilia Dalesio, Jan Festen, Jaap Hoogenhout, Paul van Houtte, Anne Kirkpatrick, Mia Koolen, Ben Maat, Arie Nijs, Alain Renaud, Patrick Rodrigus, Lon Schuster-Uitterhoeve, Jean-Paul Sculier, Nico van Zandwijk, Harry Bartelink, Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer The New England Journal of Medicine. ,vol. 326, pp. 524- 530 ,(1992) , 10.1056/NEJM199202203260805
Mitchell S. Anscher, William P. Peters, Herbert Reisenbichler, William P. Petros, Randy L. Jirtle, Transforming Growth Factor β as a Predictor of Liver and Lung Fibrosis after Autologous Bone Marrow Transplantation for Advanced Breast Cancer The New England Journal of Medicine. ,vol. 328, pp. 1592- 1598 ,(1993) , 10.1056/NEJM199306033282203
Collis Ch, Peckham Mj, Clinical objectives and normal tissue responses in combined chemotherapy and radiotherapy. Bulletin Du Cancer. ,vol. 68, pp. 132- ,(1981)
Phillips T, Pulmonary section - cardiorespiratory workshop. Cancer clinical trials. pp. 45- 52 ,(1981)
Marilyn P. Law, Vascular permeability and late radiation fibrosis in mouse lung Radiation Research. ,vol. 103, pp. 60- 76 ,(1985) , 10.2307/3576671
C. Schaake-Koning, B. Maat, P. van Houtte, W. van den Bogaert, O. Dalesio, A. Kirkpatrick, H. Bartelink, Radiotherapy Combined with Daily or Weekly cis-Diammine Dichloroplatinum (II) in Inoperable Non-Metastasized Non-Small Cell Lung Cancer: A Toxicity Report of the Randomized Phase III Study of the EORTC Lung Cancer Cooperative and Radiotherapy Cooperative Groups Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy. pp. 467- 470 ,(1991) , 10.1007/978-1-4899-0738-7_44
John Meyer, Jerome M. Vaeth, Radiation tolerance of normal tissues Karger. ,(1989)